MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank80
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
-5.29%
↑ 89% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-46.52%
Historical baseline
PeriodValue
2024-5.29%
2023-68.06%
2022-56.17%
2021-41.59%
2020-107.98%
20190.00%